Epidemiologic studies showed that hyperlipidemia was closely correlation with hypercoagulability.
流行病学研究表明，高血脂和高血凝密切相关。
Conclusions TEG shows the hypercoagulability more sensitive than other conventional coagulation parameters in CKD patients.
结论与其他常规凝血指标比较，TEG是反映CKD患者高凝状态的一个更为敏感的指标。
Chemotherapy exacerbate the hypercoagulability and microcirculation obstruction, which existed commonly in carcinomatosis mice.
小鼠荷瘤状态血液粘滞度增高，微循环障碍，化疗又进一步加重以上反应。
Objective To observe the curative effect of low molecular weight heparin(LMWH) on the hypercoagulability in acute Kawasaki disease(KD).
目的观察低分子肝素（LMWH）治疗川崎病（KD）急性期血液高凝状态的临床疗效。
Objective: To observe the effect of ShenLe Fang on hypercoagulability in nephrotic rats which are induced by adriamycin, and explore its mechanism of action.
目的：观察肾乐方改善阿霉素肾病大鼠高凝状态的效果，并探讨其作用机理。
Conclusions (1) Hypercoagulability and hyperviscosity exist in patients with acute ICH. The hemorheological parameters are influenced by hematoma volume and bleeding part.
结论(1)ich患者血液流变学呈浓、粘、聚、凝状态，血肿量及出血部位对血液流变学指标有影响。
Collectively, this can create a haemostatic defect, renal failure, uremia, thrombocytopenia which all favour bleeding but are offset due to the changes that led to hypercoagulability.
总的来说，血液系统异常可以导致止血因子缺乏、肾功能衰竭、尿毒症、血小板减少症，这些变化可以促进出血，但是可以抵消高凝状态带来的一系列改变。
AIM: To investigate the effects and safe of low molecular weight heparins (LMWH) in the treatment of patients with chronic pulmonary heart diseases (CPHD) at hypercoagulability state.
目的：观察低分子肝素(LMWH)治疗慢性肺源性心脏病合并高凝状态的疗效和安全性。
AIM: To investigate the effects and safe of low molecular weight heparins (LMWH) in the treatment of patients with chronic pulmonary heart diseases (CPHD) at hypercoagulability state.
目的：观察低分子肝素(LMWH)治疗慢性肺源性心脏病合并高凝状态的疗效和安全性。
应用推荐